THE EFFECTS OF METFORMIN ON AGING BIOMARKERS, MORBIDITY AND MORTALITY IN BURN PATIENTS - A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL (RCT)

Registry ID

237-2016

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

HAMILTON HEALTH SCIENCES CORPORATION

Start date

2020-10-09

Last update

2017-05-08

Conditions

• BURN

Related clinical trials

• SASS 2: RECONSTITUTED BILAMELLAR AUTOLOGOUS SKIN FOR PERMANENET COVERING OF ACUTE PHASE CUTANEOUS WOUNDS ON MAJOR BURN VICTIMS
• ONCE DAILY AMINOGLYCOSIDE PHARMACOKINETICS AND OPTIMAL DOSING IN THE BURN POPULATION: A PROSPECTIVE STUDY

View on source registry